FCGR2A and infection: It is hypothesized that when patients encounter a new serotype of DENV after a first infection, some of the cross-reactive antibodies from the primary infection may enhance viral entry and replication in myeloid cells by forming immune complexes and trigging Fc gamma receptor (FcγR)-mediated endocytosis [16,17].